237 related articles for article (PubMed ID: 21665989)
1. APC mutations in colorectal tumours from FAP patients are selected for CtBP-mediated oligomerization of truncated APC.
Schneikert J; Brauburger K; Behrens J
Hum Mol Genet; 2011 Sep; 20(18):3554-64. PubMed ID: 21665989
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the 15 amino acid repeats of truncated APC to beta-catenin degradation and selection of APC mutations in colorectal tumours from FAP patients.
Kohler EM; Brauburger K; Behrens J; Schneikert J
Oncogene; 2010 Mar; 29(11):1663-71. PubMed ID: 19966865
[TBL] [Abstract][Full Text] [Related]
3. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
Kohler EM; Chandra SH; Behrens J; Schneikert J
Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
[TBL] [Abstract][Full Text] [Related]
4. Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.
Crabtree M; Sieber OM; Lipton L; Hodgson SV; Lamlum H; Thomas HJ; Neale K; Phillips RK; Heinimann K; Tomlinson IP
Oncogene; 2003 Jul; 22(27):4257-65. PubMed ID: 12833148
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis of the adenomatous polyposis coli (APC) gene in northwest Spanish patients with familial adenomatous polyposis (FAP) and sporadic colorectal cancer.
Ruiz-Ponte C; Vega A; Carracedo A; Barros F
Hum Mutat; 2001 Oct; 18(4):355. PubMed ID: 11668620
[TBL] [Abstract][Full Text] [Related]
6. APC mutations in FAP-associated desmoid tumours are non-random but not 'just right'.
Latchford A; Volikos E; Johnson V; Rogers P; Suraweera N; Tomlinson I; Phillips R; Silver A
Hum Mol Genet; 2007 Jan; 16(1):78-82. PubMed ID: 17135276
[TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations.
Segditsas S; Sieber OM; Rowan A; Setien F; Neale K; Phillips RK; Ward R; Esteller M; Tomlinson IP
Exp Mol Pathol; 2008 Dec; 85(3):201-6. PubMed ID: 18977219
[TBL] [Abstract][Full Text] [Related]
8. Ovarian steroid cell tumor with biallelic adenomatous polyposis coli inactivation in a patient with familial adenomatous polyposis.
Hu PJ; Knoepp SM; Wu R; Cho KR
Genes Chromosomes Cancer; 2012 Mar; 51(3):283-9. PubMed ID: 22120905
[TBL] [Abstract][Full Text] [Related]
9. The 'just-right' signaling model: APC somatic mutations are selected based on a specific level of activation of the beta-catenin signaling cascade.
Albuquerque C; Breukel C; van der Luijt R; Fidalgo P; Lage P; Slors FJ; Leitão CN; Fodde R; Smits R
Hum Mol Genet; 2002 Jun; 11(13):1549-60. PubMed ID: 12045208
[TBL] [Abstract][Full Text] [Related]
10. Functional definition of the mutation cluster region of adenomatous polyposis coli in colorectal tumours.
Kohler EM; Derungs A; Daum G; Behrens J; Schneikert J
Hum Mol Genet; 2008 Jul; 17(13):1978-87. PubMed ID: 18387968
[TBL] [Abstract][Full Text] [Related]
11. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
Bläker H; Sutter C; Kadmon M; Otto HF; Von Knebel-Doeberitz M; Gebert J; Helmke BM
Genes Chromosomes Cancer; 2004 Oct; 41(2):93-8. PubMed ID: 15287021
[TBL] [Abstract][Full Text] [Related]
12. Adenomatous polyposis coli (APC) membrane recruitment 3, a member of the APC membrane recruitment family of APC-binding proteins, is a positive regulator of Wnt-β-catenin signalling.
Brauburger K; Akyildiz S; Ruppert JG; Graeb M; Bernkopf DB; Hadjihannas MV; Behrens J
FEBS J; 2014 Feb; 281(3):787-801. PubMed ID: 24251807
[TBL] [Abstract][Full Text] [Related]
13. [Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].
Friedrich A; Kullmann F
Med Klin (Munich); 2003 Dec; 98(12):776-82. PubMed ID: 14685680
[TBL] [Abstract][Full Text] [Related]
14. Dominant negative effect of the APC1309 mutation: a possible explanation for genotype-phenotype correlations in familial adenomatous polyposis.
Dihlmann S; Gebert J; Siermann A; Herfarth C; von Knebel Doeberitz M
Cancer Res; 1999 Apr; 59(8):1857-60. PubMed ID: 10213492
[TBL] [Abstract][Full Text] [Related]
15. Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasia.
Sumner ET; Chawla AT; Cororaton AD; Koblinski JE; Kovi RC; Love IM; Szomju BB; Korwar S; Ellis KC; Grossman SR
Oncogene; 2017 Aug; 36(33):4810-4816. PubMed ID: 28414304
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of somatic mutation of the adenomatous polyposis coli gene in colorectal tumors.
Miyaki M; Konishi M; Kikuchi-Yanoshita R; Enomoto M; Igari T; Tanaka K; Muraoka M; Takahashi H; Amada Y; Fukayama M
Cancer Res; 1994 Jun; 54(11):3011-20. PubMed ID: 8187091
[TBL] [Abstract][Full Text] [Related]
17. Mutations of the APC (adenomatous polyposis coli) gene.
Nagase H; Nakamura Y
Hum Mutat; 1993; 2(6):425-34. PubMed ID: 8111410
[TBL] [Abstract][Full Text] [Related]
18. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
Filipe B; Baltazar C; Albuquerque C; Fragoso S; Lage P; Vitoriano I; Mão de Ferro S; Claro I; Rodrigues P; Fidalgo P; Chaves P; Cravo M; Nobre Leitão C
Clin Genet; 2009 Sep; 76(3):242-55. PubMed ID: 19793053
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the APC gene in 205 families: extended genotype-phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition.
Wallis YL; Morton DG; McKeown CM; Macdonald F
J Med Genet; 1999 Jan; 36(1):14-20. PubMed ID: 9950360
[TBL] [Abstract][Full Text] [Related]
20. The APC gene product and colorectal carcinogenesis.
Bonneton C; Larue L; Thiéry JP
C R Acad Sci III; 1996 Oct; 319(10):861-9. PubMed ID: 8977766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
